世界の網膜障害治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Retinal Disorder Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4826
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、98ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、網膜障害治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ジェル、カプセル＆錠剤、点眼薬、軟膏）、用途別市場規模（病院薬局、オンライン薬局、小売薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・網膜障害治療の市場動向
・企業の競争状況、市場シェア
・網膜障害治療の種類別市場規模と予測2016-2027（ジェル、カプセル＆錠剤、点眼薬、軟膏）
・網膜障害治療の用途別市場規模と予測2016-2027（病院薬局、オンライン薬局、小売薬局）
・網膜障害治療の北米市場規模2016-2027（アメリカ、カナダ）
・網膜障害治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・網膜障害治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・網膜障害治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・網膜障害治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Santen Pharmaceutical、REGENERON、Graybug Vision、Takeda Pharmaceuticals、Bayer、Roche-Genentech、Acucela、Pfizer）
・結論

Market Analysis and Insights: Global Retinal Disorder Treatment Market
The global Retinal Disorder Treatment market size is projected to reach US$ 10890 million by 2027, from US$ 7860.7 million in 2020, at a CAGR of 4.3% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Retinal Disorder Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Retinal Disorder Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Retinal Disorder Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Retinal Disorder Treatment market.

Global Retinal Disorder Treatment Scope and Market Size
Retinal Disorder Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Retinal Disorder Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Gels
Capsules & Tablets
Eye Drops
Ointments

Segment by Application
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Santen Pharmaceutical
REGENERON
Graybug Vision
Takeda Pharmaceuticals
Bayer
Roche-Genentech
Acucela
Pfizer

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Retinal Disorder Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Gels
1.2.3 Capsules & Tablets
1.2.4 Eye Drops
1.2.5 Ointments
1.3 Market by Application
1.3.1 Global Retinal Disorder Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacy
1.3.3 Online Pharmacy
1.3.4 Retail Pharmacy
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Retinal Disorder Treatment Market Perspective (2016-2027)
2.2 Retinal Disorder Treatment Growth Trends by Regions
2.2.1 Retinal Disorder Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Retinal Disorder Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Retinal Disorder Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Retinal Disorder Treatment Industry Dynamic
2.3.1 Retinal Disorder Treatment Market Trends
2.3.2 Retinal Disorder Treatment Market Drivers
2.3.3 Retinal Disorder Treatment Market Challenges
2.3.4 Retinal Disorder Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Retinal Disorder Treatment Players by Revenue
3.1.1 Global Top Retinal Disorder Treatment Players by Revenue (2016-2021)
3.1.2 Global Retinal Disorder Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Retinal Disorder Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Retinal Disorder Treatment Revenue
3.4 Global Retinal Disorder Treatment Market Concentration Ratio
3.4.1 Global Retinal Disorder Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Retinal Disorder Treatment Revenue in 2020
3.5 Retinal Disorder Treatment Key Players Head office and Area Served
3.6 Key Players Retinal Disorder Treatment Product Solution and Service
3.7 Date of Enter into Retinal Disorder Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Retinal Disorder Treatment Breakdown Data by Type
4.1 Global Retinal Disorder Treatment Historic Market Size by Type (2016-2021)
4.2 Global Retinal Disorder Treatment Forecasted Market Size by Type (2022-2027)

5 Retinal Disorder Treatment Breakdown Data by Application
5.1 Global Retinal Disorder Treatment Historic Market Size by Application (2016-2021)
5.2 Global Retinal Disorder Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Retinal Disorder Treatment Market Size (2016-2027)
6.2 North America Retinal Disorder Treatment Market Size by Type
6.2.1 North America Retinal Disorder Treatment Market Size by Type (2016-2021)
6.2.2 North America Retinal Disorder Treatment Market Size by Type (2022-2027)
6.2.3 North America Retinal Disorder Treatment Market Size by Type (2016-2027)
6.3 North America Retinal Disorder Treatment Market Size by Application
6.3.1 North America Retinal Disorder Treatment Market Size by Application (2016-2021)
6.3.2 North America Retinal Disorder Treatment Market Size by Application (2022-2027)
6.3.3 North America Retinal Disorder Treatment Market Size by Application (2016-2027)
6.4 North America Retinal Disorder Treatment Market Size by Country
6.4.1 North America Retinal Disorder Treatment Market Size by Country (2016-2021)
6.4.2 North America Retinal Disorder Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Retinal Disorder Treatment Market Size (2016-2027)
7.2 Europe Retinal Disorder Treatment Market Size by Type
7.2.1 Europe Retinal Disorder Treatment Market Size by Type (2016-2021)
7.2.2 Europe Retinal Disorder Treatment Market Size by Type (2022-2027)
7.2.3 Europe Retinal Disorder Treatment Market Size by Type (2016-2027)
7.3 Europe Retinal Disorder Treatment Market Size by Application
7.3.1 Europe Retinal Disorder Treatment Market Size by Application (2016-2021)
7.3.2 Europe Retinal Disorder Treatment Market Size by Application (2022-2027)
7.3.3 Europe Retinal Disorder Treatment Market Size by Application (2016-2027)
7.4 Europe Retinal Disorder Treatment Market Size by Country
7.4.1 Europe Retinal Disorder Treatment Market Size by Country (2016-2021)
7.4.2 Europe Retinal Disorder Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Retinal Disorder Treatment Market Size (2016-2027)
8.2 Asia-Pacific Retinal Disorder Treatment Market Size by Type
8.2.1 Asia-Pacific Retinal Disorder Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Retinal Disorder Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Retinal Disorder Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Retinal Disorder Treatment Market Size by Application
8.3.1 Asia-Pacific Retinal Disorder Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Retinal Disorder Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Retinal Disorder Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Retinal Disorder Treatment Market Size by Region
8.4.1 Asia-Pacific Retinal Disorder Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Retinal Disorder Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Retinal Disorder Treatment Market Size (2016-2027)
9.2 Latin America Retinal Disorder Treatment Market Size by Type
9.2.1 Latin America Retinal Disorder Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Retinal Disorder Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Retinal Disorder Treatment Market Size by Type (2016-2027)
9.3 Latin America Retinal Disorder Treatment Market Size by Application
9.3.1 Latin America Retinal Disorder Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Retinal Disorder Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Retinal Disorder Treatment Market Size by Application (2016-2027)
9.4 Latin America Retinal Disorder Treatment Market Size by Country
9.4.1 Latin America Retinal Disorder Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Retinal Disorder Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Retinal Disorder Treatment Market Size (2016-2027)
10.2 Middle East & Africa Retinal Disorder Treatment Market Size by Type
10.2.1 Middle East & Africa Retinal Disorder Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Retinal Disorder Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Retinal Disorder Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Retinal Disorder Treatment Market Size by Application
10.3.1 Middle East & Africa Retinal Disorder Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Retinal Disorder Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Retinal Disorder Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Retinal Disorder Treatment Market Size by Country
10.4.1 Middle East & Africa Retinal Disorder Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Retinal Disorder Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Santen Pharmaceutical
11.1.1 Santen Pharmaceutical Company Details
11.1.2 Santen Pharmaceutical Business Overview
11.1.3 Santen Pharmaceutical Retinal Disorder Treatment Introduction
11.1.4 Santen Pharmaceutical Revenue in Retinal Disorder Treatment Business (2016-2021)
11.1.5 Santen Pharmaceutical Recent Development
11.2 REGENERON
11.2.1 REGENERON Company Details
11.2.2 REGENERON Business Overview
11.2.3 REGENERON Retinal Disorder Treatment Introduction
11.2.4 REGENERON Revenue in Retinal Disorder Treatment Business (2016-2021)
11.2.5 REGENERON Recent Development
11.3 Graybug Vision
11.3.1 Graybug Vision Company Details
11.3.2 Graybug Vision Business Overview
11.3.3 Graybug Vision Retinal Disorder Treatment Introduction
11.3.4 Graybug Vision Revenue in Retinal Disorder Treatment Business (2016-2021)
11.3.5 Graybug Vision Recent Development
11.4 Takeda Pharmaceuticals
11.4.1 Takeda Pharmaceuticals Company Details
11.4.2 Takeda Pharmaceuticals Business Overview
11.4.3 Takeda Pharmaceuticals Retinal Disorder Treatment Introduction
11.4.4 Takeda Pharmaceuticals Revenue in Retinal Disorder Treatment Business (2016-2021)
11.4.5 Takeda Pharmaceuticals Recent Development
11.5 Bayer
11.5.1 Bayer Company Details
11.5.2 Bayer Business Overview
11.5.3 Bayer Retinal Disorder Treatment Introduction
11.5.4 Bayer Revenue in Retinal Disorder Treatment Business (2016-2021)
11.5.5 Bayer Recent Development
11.6 Roche-Genentech
11.6.1 Roche-Genentech Company Details
11.6.2 Roche-Genentech Business Overview
11.6.3 Roche-Genentech Retinal Disorder Treatment Introduction
11.6.4 Roche-Genentech Revenue in Retinal Disorder Treatment Business (2016-2021)
11.6.5 Roche-Genentech Recent Development
11.7 Acucela
11.7.1 Acucela Company Details
11.7.2 Acucela Business Overview
11.7.3 Acucela Retinal Disorder Treatment Introduction
11.7.4 Acucela Revenue in Retinal Disorder Treatment Business (2016-2021)
11.7.5 Acucela Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Details
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Retinal Disorder Treatment Introduction
11.8.4 Pfizer Revenue in Retinal Disorder Treatment Business (2016-2021)
11.8.5 Pfizer Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Retinal Disorder Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Gels
Table 3. Key Players of Capsules & Tablets
Table 4. Key Players of Eye Drops
Table 5. Key Players of Ointments
Table 6. Global Retinal Disorder Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Retinal Disorder Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Retinal Disorder Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Retinal Disorder Treatment Market Share by Regions (2016-2021)
Table 10. Global Retinal Disorder Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Retinal Disorder Treatment Market Share by Regions (2022-2027)
Table 12. Retinal Disorder Treatment Market Trends
Table 13. Retinal Disorder Treatment Market Drivers
Table 14. Retinal Disorder Treatment Market Challenges
Table 15. Retinal Disorder Treatment Market Restraints
Table 16. Global Retinal Disorder Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Retinal Disorder Treatment Market Share by Players (2016-2021)
Table 18. Global Top Retinal Disorder Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retinal Disorder Treatment as of 2020)
Table 19. Ranking of Global Top Retinal Disorder Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Retinal Disorder Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Retinal Disorder Treatment Product Solution and Service
Table 23. Date of Enter into Retinal Disorder Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Retinal Disorder Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Retinal Disorder Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Retinal Disorder Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Retinal Disorder Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Retinal Disorder Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Retinal Disorder Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Retinal Disorder Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Retinal Disorder Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Retinal Disorder Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Retinal Disorder Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Retinal Disorder Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Retinal Disorder Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Retinal Disorder Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Retinal Disorder Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Retinal Disorder Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Retinal Disorder Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Retinal Disorder Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Retinal Disorder Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Retinal Disorder Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Retinal Disorder Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Retinal Disorder Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Retinal Disorder Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Retinal Disorder Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Retinal Disorder Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Retinal Disorder Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Retinal Disorder Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Retinal Disorder Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Retinal Disorder Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Retinal Disorder Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Retinal Disorder Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Retinal Disorder Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Retinal Disorder Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Retinal Disorder Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Retinal Disorder Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Retinal Disorder Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Retinal Disorder Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Retinal Disorder Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Retinal Disorder Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. Santen Pharmaceutical Company Details
Table 64. Santen Pharmaceutical Business Overview
Table 65. Santen Pharmaceutical Retinal Disorder Treatment Product
Table 66. Santen Pharmaceutical Revenue in Retinal Disorder Treatment Business (2016-2021) & (US$ Million)
Table 67. Santen Pharmaceutical Recent Development
Table 68. REGENERON Company Details
Table 69. REGENERON Business Overview
Table 70. REGENERON Retinal Disorder Treatment Product
Table 71. REGENERON Revenue in Retinal Disorder Treatment Business (2016-2021) & (US$ Million)
Table 72. REGENERON Recent Development
Table 73. Graybug Vision Company Details
Table 74. Graybug Vision Business Overview
Table 75. Graybug Vision Retinal Disorder Treatment Product
Table 76. Graybug Vision Revenue in Retinal Disorder Treatment Business (2016-2021) & (US$ Million)
Table 77. Graybug Vision Recent Development
Table 78. Takeda Pharmaceuticals Company Details
Table 79. Takeda Pharmaceuticals Business Overview
Table 80. Takeda Pharmaceuticals Retinal Disorder Treatment Product
Table 81. Takeda Pharmaceuticals Revenue in Retinal Disorder Treatment Business (2016-2021) & (US$ Million)
Table 82. Takeda Pharmaceuticals Recent Development
Table 83. Bayer Company Details
Table 84. Bayer Business Overview
Table 85. Bayer Retinal Disorder Treatment Product
Table 86. Bayer Revenue in Retinal Disorder Treatment Business (2016-2021) & (US$ Million)
Table 87. Bayer Recent Development
Table 88. Roche-Genentech Company Details
Table 89. Roche-Genentech Business Overview
Table 90. Roche-Genentech Retinal Disorder Treatment Product
Table 91. Roche-Genentech Revenue in Retinal Disorder Treatment Business (2016-2021) & (US$ Million)
Table 92. Roche-Genentech Recent Development
Table 93. Acucela Company Details
Table 94. Acucela Business Overview
Table 95. Acucela Retinal Disorder Treatment Product
Table 96. Acucela Revenue in Retinal Disorder Treatment Business (2016-2021) & (US$ Million)
Table 97. Acucela Recent Development
Table 98. Pfizer Company Details
Table 99. Pfizer Business Overview
Table 100. Pfizer Revenue in Retinal Disorder Treatment Business (2016-2021) & (US$ Million)
Table 101. Pfizer Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Retinal Disorder Treatment Market Share by Type: 2020 VS 2027
Figure 2. Gels Features
Figure 3. Capsules & Tablets Features
Figure 4. Eye Drops Features
Figure 5. Ointments Features
Figure 6. Global Retinal Disorder Treatment Market Share by Application: 2020 VS 2027
Figure 7. Hospital Pharmacy Case Studies
Figure 8. Online Pharmacy Case Studies
Figure 9. Retail Pharmacy Case Studies
Figure 10. Retinal Disorder Treatment Report Years Considered
Figure 11. Global Retinal Disorder Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Retinal Disorder Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Retinal Disorder Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Retinal Disorder Treatment Market Share by Regions (2022-2027)
Figure 15. Global Retinal Disorder Treatment Market Share by Players in 2020
Figure 16. Global Top Retinal Disorder Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retinal Disorder Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Retinal Disorder Treatment Revenue in 2020
Figure 18. Global Retinal Disorder Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Retinal Disorder Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Retinal Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Retinal Disorder Treatment Market Share by Type (2016-2027)
Figure 22. North America Retinal Disorder Treatment Market Share by Application (2016-2027)
Figure 23. North America Retinal Disorder Treatment Market Share by Country (2016-2027)
Figure 24. United States Retinal Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Retinal Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Retinal Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Retinal Disorder Treatment Market Share by Type (2016-2027)
Figure 28. Europe Retinal Disorder Treatment Market Share by Application (2016-2027)
Figure 29. Europe Retinal Disorder Treatment Market Share by Country (2016-2027)
Figure 30. Germany Retinal Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Retinal Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Retinal Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Retinal Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Retinal Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Retinal Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Retinal Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Retinal Disorder Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Retinal Disorder Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Retinal Disorder Treatment Market Share by Region (2016-2027)
Figure 40. China Retinal Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Retinal Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Retinal Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Retinal Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Retinal Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Retinal Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Retinal Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Retinal Disorder Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Retinal Disorder Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Retinal Disorder Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Retinal Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Retinal Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Retinal Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Retinal Disorder Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Retinal Disorder Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Retinal Disorder Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Retinal Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Retinal Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Retinal Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Santen Pharmaceutical Revenue Growth Rate in Retinal Disorder Treatment Business (2016-2021)
Figure 60. REGENERON Revenue Growth Rate in Retinal Disorder Treatment Business (2016-2021)
Figure 61. Graybug Vision Revenue Growth Rate in Retinal Disorder Treatment Business (2016-2021)
Figure 62. Takeda Pharmaceuticals Revenue Growth Rate in Retinal Disorder Treatment Business (2016-2021)
Figure 63. Bayer Revenue Growth Rate in Retinal Disorder Treatment Business (2016-2021)
Figure 64. Roche-Genentech Revenue Growth Rate in Retinal Disorder Treatment Business (2016-2021)
Figure 65. Acucela Revenue Growth Rate in Retinal Disorder Treatment Business (2016-2021)
Figure 66. Pfizer Revenue Growth Rate in Retinal Disorder Treatment Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

以下、関連資料のご紹介

世界の網膜用生物製剤市場規模・現状・予測（2021年-2027年）

Global Retinal Biologics Market Size, Status and Forecast 2021-2027
QFJ1-4821 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、網膜用生物製剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（黄斑変性症、糖尿病性網膜症、糖尿病性黄斑浮腫、ブドウ膜炎、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、...

世界のオピオイド使用障害市場規模・現状・予測（2021年-2027年）

Global Opioid Use Disorder Market Size, Status and Forecast 2021-2027
QFJ1-4617 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、オピオイド使用障害の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ブプレノルフィン、メタドン、ナルトレキソン）、用途別市場規模（中等度疼痛治療、重度疼痛治療）、主要地域別市場規模（北米、アメリカ、欧州...

世界の甲状腺障害市場規模・現状・予測（2021年-2027年）

Global Thyroid Disorder Market Size, Status and Forecast 2021-2027
QFJ1-6041 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、甲状腺障害の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（甲状腺機能低下症、甲状腺機能亢進症）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓...

世界の月経前不快気分障害（PMDD）市場規模・現状・予測（2021年-2027年）

Global Premenstrual Dysphoric Disorder (PMDD) Market Size, Status and Forecast 2021-2027
QFJ1-4754 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、月経前不快気分障害（PMDD）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（錠剤、注入剤、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本...

世界の糖尿病性神経障害治療薬市場規模・現状・予測（2021年-2027年）

Global Diabetic Neurological Disorder Therapeutic Drug Market Size, Status and Forecast 2021-2027
QFJ1-4124 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、糖尿病性神経障害治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（カプセル、ピル、その他）、用途別市場規模（対称性神経障害、焦点＆多巣性神経障害）、主要地域別市場規模（北米、アメリカ、欧州、アジア...

世界の季節性情動障害治療薬市場規模・現状・予測（2021年-2027年）

Global Seasonal Affective Disorder Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-4850 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、季節性情動障害治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（光線療法、薬物治療、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中...

世界の代謝性疾患治療薬市場規模・現状・予測（2021年-2027年）

Global Metabolic Disorder Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-5852 2021年6月 118Pages
QYResearch社発行の本調査レポートでは、代謝性疾患治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（リソソーム蓄積症、糖尿病、肥満、先天性代謝異常症、高コレステロール血症）、用途別市場規模（経口、非経口、その他）、主要地域別市場規模（北...

世界の未分化甲状腺がん治療市場規模・現状・予測（2021年-2027年）

Global Anaplastic Thyroid Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3803 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、未分化甲状腺がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

世界のOAB治療市場規模・現状・予測（2021年-2027年）

Global OAB Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5902 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、OAB治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗コリン作用薬、ミラベグロン、ボトックス）、用途別市場規模（特発性過活動膀胱、神経性過活動膀胱）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界の視神経スペクトラム障害（NMOSD）市場規模・現状・予測（2021年-2027年）

Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size, Status and Forecast 2021-2027
QFJ1-4571 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、視神経スペクトラム障害（NMOSD）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（静脈注射、経口、皮下、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州...

世界の網膜用生物製剤市場規模・現状・予測（2021年-2027年） Many retinal biologics have been approved by the Food and Drug Administration (FDA), the European Medicine Agency (EMA) and the China Food and Drug Administration (CFDA) for the treatment of retinal diseases. Advancements in technologies and new mechanism of action for different biologics to treat r…
世界のオピオイド使用障害市場規模・現状・予測（2021年-2027年） An opioid is a synthetic or natural agent that stimulates opioid receptors and produces opium-like effects. Opioid use disorder is a problematic pattern of opioid use that causes significant impairment or distress. Increase in opioid epidemic in the U.S. coupled with establishment of government poli…
世界の甲状腺障害市場規模・現状・予測（2021年-2027年） Thyroid disorders may lead to elevated or decreased levels of metabolic hormones, leading to medical conditions such as hypothyroidism, hyperthyroidism, etc. falling under the category of thyroid disorders. The global thyroid disorder market is estimated to be driven by the increasing prevalence of …
世界の月経前不快気分障害（PMDD）市場規模・現状・予測（2021年-2027年） Premenstrual dysphoric disorder (PMDD) is a health problem that is similar to premenstrual syndrome (PMS) but is more serious. PMDD causes severe irritability, depression, or anxiety in the week or two before your period starts. Symptoms usually go away two to three days after your period starts. Ma…
世界の糖尿病性神経障害治療薬市場規模・現状・予測（2021年-2027年） A drug used to treat mental illness caused by diabetes Market Analysis and Insights: Global Diabetic Neurological Disorder Therapeutic Drug Market The global Diabetic Neurological Disorder Therapeutic Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CA…